These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 27630276)
1. DNA Methylation Machinery in the Endometrium and Endometrial Cancer. Caplakova V; Babusikova E; Blahovcova E; Balharek T; Zelieskova M; Hatok J Anticancer Res; 2016 Sep; 36(9):4407-20. PubMed ID: 27630276 [TBL] [Abstract][Full Text] [Related]
2. DNA methylation as mechanism of apoptotic resistance development in endometrial cancer patients. Fialkova V; Vidomanova E; Balharek T; Marcinek J; Kudela E; Hanysova S; Visnovsky J; Dobrota D; Hatok J Gen Physiol Biophys; 2017 Dec; 36(5):521-529. PubMed ID: 29372685 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of endometrium during the menstrual cycle. Munro SK; Farquhar CM; Mitchell MD; Ponnampalam AP Mol Hum Reprod; 2010 May; 16(5):297-310. PubMed ID: 20139117 [TBL] [Abstract][Full Text] [Related]
4. Human endometrial DNA methylome is cycle-dependent and is associated with gene expression regulation. Houshdaran S; Zelenko Z; Irwin JC; Giudice LC Mol Endocrinol; 2014 Jul; 28(7):1118-35. PubMed ID: 24877562 [TBL] [Abstract][Full Text] [Related]
5. Aberrant Endometrial DNA Methylome and Associated Gene Expression in Women with Endometriosis. Houshdaran S; Nezhat CR; Vo KC; Zelenko Z; Irwin JC; Giudice LC Biol Reprod; 2016 Nov; 95(5):93. PubMed ID: 27535958 [TBL] [Abstract][Full Text] [Related]
6. [Estimation of DNA methylation level in endometrial cancer tissues]. Popiela A; Gabryś MS; Rabczyński J; Pańszczyk M; Keith G; Baranowski W Ginekol Pol; 2002 Nov; 73(11):966-9. PubMed ID: 12722383 [TBL] [Abstract][Full Text] [Related]
7. Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics. Banno K; Yanokura M; Iida M; Masuda K; Aoki D J Obstet Gynaecol Res; 2014 Aug; 40(8):1957-67. PubMed ID: 25131761 [TBL] [Abstract][Full Text] [Related]
8. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma. Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461 [TBL] [Abstract][Full Text] [Related]
9. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma. Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468 [TBL] [Abstract][Full Text] [Related]
10. The influence of menstrual cycle and endometriosis on endometrial methylome. Saare M; Modhukur V; Suhorutshenko M; Rajashekar B; Rekker K; Sõritsa D; Karro H; Soplepmann P; Sõritsa A; Lindgren CM; Rahmioglu N; Drong A; Becker CM; Zondervan KT; Salumets A; Peters M Clin Epigenetics; 2016; 8():2. PubMed ID: 26759613 [TBL] [Abstract][Full Text] [Related]
11. Caspase cascade of Fas-mediated apoptosis in human normal endometrium and endometrial carcinoma cells. Abe H; Shibata MA; Otsuki Y Mol Hum Reprod; 2006 Sep; 12(9):535-41. PubMed ID: 16870953 [TBL] [Abstract][Full Text] [Related]
12. The endometrial epigenome and its response to steroid hormones. Guo SW Mol Cell Endocrinol; 2012 Jul; 358(2):185-96. PubMed ID: 22067514 [TBL] [Abstract][Full Text] [Related]
13. Importance of promoter methylation of GATA4 and TP53 genes in endometrioid carcinoma of endometrium. Chmelarova M; Kos S; Dvorakova E; Spacek J; Laco J; Ruszova E; Hrochova K; Palicka V Clin Chem Lab Med; 2014 Aug; 52(8):1229-34. PubMed ID: 24651021 [TBL] [Abstract][Full Text] [Related]
14. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer. Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic DNA hypermethylation: clinical applications in endometrial cancer (Review). Muraki Y; Banno K; Yanokura M; Kobayashi Y; Kawaguchi M; Nomura H; Hirasawa A; Susumu N; Aoki D Oncol Rep; 2009 Nov; 22(5):967-72. PubMed ID: 19787208 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma. Vaskivuo TE; Stenbäck F; Tapanainen JS Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915 [TBL] [Abstract][Full Text] [Related]
17. Nuclear localization of beta-catenin in normal and carcinogenic endometrium. Nei H; Saito T; Yamasaki H; Mizumoto H; Ito E; Kudo R Mol Carcinog; 1999 Jul; 25(3):207-18. PubMed ID: 10411147 [TBL] [Abstract][Full Text] [Related]
18. Expression of type 2 orexin receptor in human endometrium and its epigenetic silencing in endometrial cancer. Dehan P; Canon C; Trooskens G; Rehli M; Munaut C; Van Criekinge W; Delvenne P J Clin Endocrinol Metab; 2013 Apr; 98(4):1549-57. PubMed ID: 23482607 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis in the human uterine endometrium during the menstrual cycle. Kokawa K; Shikone T; Nakano R J Clin Endocrinol Metab; 1996 Nov; 81(11):4144-7. PubMed ID: 8923873 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of pro-apoptotic Par-4 by NF-kappaB/p65 and its function in controlling cell kinetics during early events in endometrial tumourigenesis. Saegusa M; Hashimura M; Kuwata T; Okayasu I J Pathol; 2010 May; 221(1):26-36. PubMed ID: 20186924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]